SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-052739
Filing Date
2020-11-10
Accepted
2020-11-10 07:31:02
Documents
58
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 Q3 2020 10-Q grtx-10q_20200930.htm 10-Q 1723532
2 EX-31.1 grtx-ex311_7.htm EX-31.1 18120
3 EX-31.2 grtx-ex312_9.htm EX-31.2 19311
4 EX-32.1 grtx-ex321_6.htm EX-32.1 8473
5 EX-32.2 grtx-ex322_11.htm EX-32.2 8280
  Complete submission text file 0001564590-20-052739.txt   5207530

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT grtx-20200930.xml EX-101.INS 978811
7 XBRL TAXONOMY EXTENSION SCHEMA grtx-20200930.xsd EX-101.SCH 38698
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE grtx-20200930_cal.xml EX-101.CAL 40652
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE grtx-20200930_def.xml EX-101.DEF 86991
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE grtx-20200930_lab.xml EX-101.LAB 306194
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE grtx-20200930_pre.xml EX-101.PRE 219726
Mailing Address 2 WEST LIBERTY BLVD #100 MALVERN PA 19355
Business Address 2 WEST LIBERTY BLVD #100 MALVERN PA 19355 610-725-1500
Galera Therapeutics, Inc. (Filer) CIK: 0001563577 (see all company filings)

IRS No.: 461454898 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39114 | Film No.: 201299642
SIC: 2834 Pharmaceutical Preparations